Aspira Pathlab & Diagnostics informs about disclosure

09 Apr 2024 Evaluate
Aspira Pathlab & Diagnostics has confirmed that Aspira Pathlab & Diagnostics does not qualify for Large Corporate (LC) in accordance with the criteria provided by SEBI vide Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. Accordingly, Annual Disclosure as mentioned in Annexure B2 of the said circular for the financial year 2023-2024 is not applicable to the Company.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.03 2.03 (3.83%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.